First FDA approved cannabis-based drug now available by prescription

The first cannabis-derived medication approved by the Food and Drug Administration is now available by prescription in every state, according to its manufacturer.

Epidiolex, manufactured by GW Pharmaceuticals, is intended to treat seizures associated with two rare and severe forms of epilepsy that begin in childhood. The drug is made of cannabidiol (CBD), a component of marijuana that doesn’t give users a high.

Continue reading “First FDA approved cannabis-based drug now available by prescription”

“CBD candy” is this year’s Halloween bogeyman

Every year around this time, The Cannabist chronicles how THC became the new razor blade in your kid’s trick-or-treat pail.

With Halloween 2017 right around the corner, it looks like there’s a new bogeyman, at least in some parts of the country: “CBD candy.” Continue reading ““CBD candy” is this year’s Halloween bogeyman”

Going into its fourth harvest, industrial hemp industry still facing growing pains

The first hint that Damian Farris isn’t your typical farmer is the nickname of his mud-splattered white pickup truck: “Smoked Tofu.”

Four years ago he was a hippie with no farming experience and a passion for weed. Now he’s the co-founder of Colorado Cultivars, the self-proclaimed country’s largest hemp farm, just east of Eaton. The marijuana dispensary owner turned industrial hemp grower navigates the farm’s sprawling fields like an old pro. Continue reading “Going into its fourth harvest, industrial hemp industry still facing growing pains”

Denver officials scrutinizing out-of-state CBD products sold in local pot shops

Denver is clamping down on CBD products that originate outside of Colorado.

A bulletin issued Wednesday by Denver Environmental Health’s Public Health Inspections Division outlines a policy prohibiting out-of-state-made cannabidiol (CBD) products intended for human consumption. Continue reading “Denver officials scrutinizing out-of-state CBD products sold in local pot shops”

GW Pharma Takes A Step Toward Diversifying

Being a one-trick pony can always prove risky. This rationale seems to have dawned on GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company specializing in prescription cannabinoid medicine. Continue reading “GW Pharma Takes A Step Toward Diversifying”

Possible NFL marijuana policy change? Commissioner Roger Goodell chimes in.

The league is listening. But it wants facetime.

The NFL Players’ Association recently announced its intent to propose to the league a “less punitive” approach to dealing with recreational marijuana use among players.

“I do think that issues of addressing it more in a treatment and less punitive measure is appropriate,” union executive director DeMaurice Smith told The Washington Post. Continue reading “Possible NFL marijuana policy change? Commissioner Roger Goodell chimes in.”

New DEA rule on extracts, CBD riles cannabis industry

Continue reading “New DEA rule on extracts, CBD riles cannabis industry”